AFP and neoplasm: The propensity-score model included gender, serum alpha-fetoprotein (AFP) levels before treatment (≤ or > 400 ng/ml), tumor numbers (single or multiple), liver involvement (unilateral or bilateral), macrovascular invasion (absent or present), and distant metastasis (absent or present).